Emraclidine
- Generic Name
- Emraclidine
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects
- First Posted Date
- 2017-07-14
- Last Posted Date
- 2018-02-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 17
- Registration Number
- NCT03217604
- Locations
- 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath